Tag : Molecular Diagnostics

Latest News

New data demonstrates clinical utility of AlloSure in repeat kidney transplant recipients

Newsemia
CareDx, Inc., a leading molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, today announces...
Latest News

New York State approves NYGC's Whole Genome and Transcriptome Sequencing for oncology

Newsemia
The New York Genome Center has received approval from the New York State Department of Health to offer whole genome and RNA transcriptome sequencing in...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy